English
Spanish
New COVID-19 Exposure App
The New Mexico Department of Health has announced the launch of a COVID-19 Exposure Notification System, NM Notify. When activated on a Smart Phone, the app alerts individuals when they have been exposed to someone who has verified that they are infected with COVID-19.
Read More ›
CDC Update on Johnson & Johnson COVID-19 Vaccine
The CDC and FDA have recommended a pause in the use of the Johnson & Johnson COVID-19 vaccine out of an abundance of caution after six reported U.S. cases (out of more than 6.8 million doses) of a rare and severe type of blood clot in individuals after receiving the J&J vaccine.
Read More ›
Updated COVID-19 Travel Guidelines
On Friday, April 2, the Centers for Disease Control and Prevention (CDC) updated its travel guidance for fully vaccinated people to reflect the latest evidence and science. Given recent studies evaluating the real-world effects of vaccination, CDC recommends that fully vaccinated people can travel at low risk to themselves.
Read More ›
All New Mexicans age 16 and older are eligible for COVID-19...
New Mexico Department of Health (NMDOH) has announced that, as of Monday, April 5, 2021, all New Mexicans age 16 and older are now eligible for COVID-19 vaccine. NMDOH encourages all New Mexicans to register at vaccineNM.org
Read More ›
Guidance for Fully Vaccinated People
The CDC released Interim Public Health Recommendations for Fully Vaccinated People. For the purposes of this guidance, people are considered fully vaccinated for COVID-19 2 weeks after they have received the second dose in a 2-dose series, or 2 weeks after they have received a single-dose vaccine. This guidance will be updated and expanded as more people become vaccinated and more information becomes available.
Read More ›
Third COVID-19 Vaccine Authorized
On February 27, 2021, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older for the prevention of COVID-19.
Read More ›